
Adverse effects of a SOD1-peptide immunotherapy on SOD1G93A mouse slow model of amyotrophic lateral sclerosis
Keywords: ALS; amyotrophic lateral sclerosis; CS; clinical score; ELISA; enzyme-linked immunosorbent assay; FALS; familial amyotrophic lateral sclerosis; GFAP; glial fibrillary acidic protein; Iba-1; ionized calcium binding adaptor molecule; IgG; immunoglobulin G;